1. Home
  2. DV vs MNKD Comparison

DV vs MNKD Comparison

Compare DV & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DoubleVerify Holdings Inc.

DV

DoubleVerify Holdings Inc.

HOLD

Current Price

$9.43

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$5.67

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DV
MNKD
Founded
2008
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
DV
MNKD
Price
$9.43
$5.67
Analyst Decision
Buy
Strong Buy
Analyst Count
17
6
Target Price
$16.59
$10.08
AVG Volume (30 Days)
2.6M
3.8M
Earning Date
02-26-2026
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
23.47
EPS
0.26
0.10
Revenue
$733,324,000.00
$313,787,000.00
Revenue This Year
$17.87
$21.29
Revenue Next Year
$10.36
$25.53
P/E Ratio
$35.93
$57.82
Revenue Growth
14.86
17.43
52 Week Low
$7.64
$3.38
52 Week High
$23.11
$6.51

Technical Indicators

Market Signals
Indicator
DV
MNKD
Relative Strength Index (RSI) 32.28 47.64
Support Level $9.07 $5.54
Resistance Level $9.96 $6.05
Average True Range (ATR) 0.45 0.29
MACD -0.10 -0.02
Stochastic Oscillator 13.06 25.88

Price Performance

Historical Comparison
DV
MNKD

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: